Co-regulation of transcription by AR and FOXA1 in prostate cancer is associated with reprogrammed binding of AR and oncogenic patterns of gene expression that are essential for AR-driven proliferation [92, 97]. This evidence concerns the gene AR and prostate carcinoma.